NephrosNEPH
NEPH logo
Fair Value
US$4.75
Share price15 Aug
US$4.0814.1% undervalued intrinsic discount
Loading
1Y-2.39%
7D-11.78%

Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact

Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
16 Dec 25
Updated
15 Aug 26
Views
23
Not Invested

Fair Value vs Share Price

US$4.75
vs US$4.0814.1% undervalued intrinsic discount
PastFuture-4m33m2015201820212024202620272029Revenue US$33.3mEarnings US$4.7m
17.2%
Revenue growth
14%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Nephros

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet and good value.

Market capUS$47.8m
PB3.7x
Estimated Growth13.8%
Dividend YieldN/A
Full analysis

CEO & management

Robert Banks
CEO
3.6yrs
CEO Tenure

A commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States.